No abstract available
MeSH terms
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / pharmacology
-
Antigens, CD*
-
Cell Division / drug effects
-
Cytokine Receptor gp130
-
Growth Inhibitors / pharmacology
-
Humans
-
Interleukin-11 / pharmacology
-
Interleukin-11 Receptor alpha Subunit
-
Interleukin-6 / pharmacology
-
Leukemia Inhibitory Factor
-
Leukemia Inhibitory Factor Receptor alpha Subunit
-
Lymphokines / pharmacology
-
Macromolecular Substances
-
Male
-
Membrane Glycoproteins / antagonists & inhibitors
-
Membrane Glycoproteins / immunology
-
Membrane Glycoproteins / physiology*
-
Middle Aged
-
Multiple Myeloma / pathology*
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm Proteins / immunology
-
Neoplasm Proteins / physiology*
-
Oncostatin M
-
Peptides / pharmacology
-
Plasmacytoma / pathology*
-
Receptors, Cytokine / drug effects
-
Receptors, Interleukin / drug effects*
-
Receptors, Interleukin / physiology
-
Receptors, Interleukin-11
-
Receptors, Interleukin-6
-
Receptors, OSM-LIF
-
Receptors, Oncostatin M
-
Signal Transduction / drug effects*
-
Tumor Cells, Cultured / drug effects
Substances
-
Antibodies, Monoclonal
-
Antigens, CD
-
Growth Inhibitors
-
IL11RA protein, human
-
IL6ST protein, human
-
Interleukin-11
-
Interleukin-11 Receptor alpha Subunit
-
Interleukin-6
-
LIF protein, human
-
LIFR protein, human
-
Leukemia Inhibitory Factor
-
Leukemia Inhibitory Factor Receptor alpha Subunit
-
Lymphokines
-
Macromolecular Substances
-
Membrane Glycoproteins
-
Neoplasm Proteins
-
OSM protein, human
-
Peptides
-
Receptors, Cytokine
-
Receptors, Interleukin
-
Receptors, Interleukin-11
-
Receptors, Interleukin-6
-
Receptors, OSM-LIF
-
Receptors, Oncostatin M
-
Oncostatin M
-
Cytokine Receptor gp130